1.Epidemiologic study of chronic kidney disease in Changsha county of Hunan province
Ying LI ; Letian ZHOU ; Fuyou LIU ; Jun LI ; Youming PENG ; Lijun YANG ; Xiang PENG ; Wenbin TANG ; Yayi HE ; Jingwen WU ; Jinding PENG ; Dejun WANG ; Jun CHEN
Chinese Journal of Nephrology 2010;26(1):9-14
Objective To investigate the prevalence of chronic kidney disease (CKD) and associated factors in Changsha county of Hunan province. Methods Using a stratified, multistage sampling, 1950 residents (older than 20 years old) from 3 towns of Changsha county were randomly selected to be interviewed and tested for the kidney damage indicators and the associated factors with CKD. Results Eligible data of 1727 subjects were enrolled in the study. After the adjustment of age and gender compenent, the prevalence of albuminuria was 8.5%, hematuria 5.1%, and reduced eGFR 1.5%. Approximately 14.6% subjects had at least one indicator of kidney damage, and the awareness rate was 16.5%. Age, hypercholesteremia, hypertriglyceridemia, hypertension and diabetes were independently correlated with albuminuria. Female, age, hypertriglyceridemia and hyperuricemia were independently correlated with reduced renal function. Female was independently correlated with hematuria. Conclusions The prevalence of chronic kidney disease is 14.6% and the awareness rate is 16.5% in suburban adult population of the central south area of China. The spectrum and correlated factors of CKD in this county undergoing fast economic development are close to those of Guangzhou and developed countries.
2.Systematic review and comment on modern study of Xiaojin Pills.
Xi XIONG ; Bi FENG ; Bo CAO ; Ding-Kun ZHANG ; Kai-Peng XIONG ; Jun-Zhi LIN ; Zhi-Min CI ; Run-Chun XU ; Li HAN
China Journal of Chinese Materia Medica 2018;43(24):4801-4807
Xiaojin Pill, was firstly recorded in Life-saving Manual of Diagnosis and Treatment of External Diseases, with its primitive name of "Xiaojin Dan". Xiaojin Pill is a classic prescription for treating carbuncle and it is the first choice for Chinese medicine in the clinical treatment of hyperplasia of mammary glands. In this paper, the literature reports on Xiaojin Pills were summarized and the historical evolution, material basis, pharmacological action, quality control and other problems were systematically discussed to explore the potential problems in every aspect of the development status, and put forward the development countermeasures, providing reference for the modernization research and development of Xiaojin Pills.
Capsules
;
Drugs, Chinese Herbal
;
Quality Control
;
Research